Crossmark

Indole-based LpxC (UDP-3-O-(R-3-hydroxyacyl)-N-acetylglucosaminedeacetylase) inhibitors for Salmonella typhi: rational drug discovery through in silico screening

Crossref DOI link: https://doi.org/10.1007/s13205-023-03699-5

Published Online: 2023-07-24

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kumar Pal, Sudhir

Kumar, Sanjit https://orcid.org/0009-0002-5991-1936
Funding

Funding for this research was provided by:

ICMR (BMI/11(30)/2020)
License Information

Text and Data Mining valid from 2023-07-24

Version of Record valid from 2023-07-24
More Information

Article History

Received: 23 April 2023

Accepted: 10 July 2023

First Online: 24 July 2023

Declarations

:

: All co-authors have agreed to submit the manuscript to the journal. The findings have not been published elsewhere. The manuscript is not currently under consideration by another journal. The authors declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below